Internal Medicine, Hematology & Oncology · Boaz, AL
NPI
1659568012
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2505 US Hwy 431
Boaz, AL, 35957
Phone (256) 840-3688
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
976 services
Medicare patients, 2024
282
Average age 76
Drug cost, 2024
$3.4M
1,232 prescriptions
Company payments, 2025
$2,571
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan A Storey was code 99214 (office e&m - established), 633 times for 183 patients. In total Jonathan A Storey billed 976 services in 9 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 633 | 183 | $64.69 | $41K |
| 99213 Office E&M - Established | Office | 173 | 136 | $43.19 | $7,472 |
| 99215 Office E&M - Established | Office | 109 | 64 | $103.14 | $11K |
| 99205 Office E&M - New | Office | 46 | 46 | $131.83 | $6,064 |
By year: 2022 $82K for 1,178 services; 2023 $77K for 1,132 services; 2024 $67K for 976 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan A Storey prescribed most often to Medicare patients was Anastrozole, with 227 prescriptions and refills. In total Jonathan A Storey wrote 1,232 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 227 | 358 | 46 | $2,625 |
| Ondansetron Hcl Generic | 88 | 88 | 39 | $1,429 |
| Prednisone Generic | 76 | 76 | 20 | $453 |
| Eliquis Apixaban | 62 | 84 | 15 | $48K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 60 | 60 | 12 | $1,183 |
| Hydroxyurea Generic | 56 | 72 | Under 11 | $1,004 |
| Inqovi Decitabine/Cedazuridine | 32 | 32 | Under 11 | $267K |
| Letrozole Generic | 32 | 34 | Under 11 | $376 |
| Brukinsa Zanubrutinib | 31 | 31 | Under 11 | $458K |
| Warfarin Sodium Generic | 30 | 36 | Under 11 | $137 |
| Abiraterone Acetate Generic | 30 | 30 | Under 11 | $153K |
| Dexamethasone Generic | 26 | 26 | Under 11 | $478 |
| Gabapentin Generic | 23 | 23 | Under 11 | $237 |
| Promacta Eltrombopag Olamine | 22 | 22 | Under 11 | $301K |
| Venclexta Venetoclax | 21 | 21 | Under 11 | $179K |
Brand drugs: 318 claims; generic drugs: 914 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan A Storey $2,571 ($2,571 in general payments such as food, travel and fees) from 38 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $215.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $215 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $201 |
| Merck Sharp & Dohme LLC MRK | 9 | $196 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $194 |
| Abbvie Inc. ABBV | 8 | $165 |
| Pfizer Inc. PFE | 9 | $162 |
| Daiichi Sankyo Inc. 4568.T | 5 | $110 |
| Janssen Biotech, Inc. JNJ | 5 | $95.96 |
| Lilly USA, LLC LLY | 5 | $93.18 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $78.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.